Regain Laser Therapy
Regain Laser Therapy
Company Overview
Regain Laser Therapy is a US-based medical device platform company with a strategic focus on regenerative medicine. Our proprietary, non-invasive, laser platform offers an exciting investment opportunity in the healthcare sector. We have developed a patented medical device with prototypes currently in use by clinicians and elite athletes. Our disruptive technology offers clear competitive advantages, facilitating faster and more effective healing, outperforming standard of care modalities. Our first product, the Regain Warrior, is a portable medical device suitable for in-office, at-home, or on-field use. It offers fast, pain-free, non-contact treatments with zero downtime. The Warrior is strategically positioned to excel in three substantial markets: the $12 billion US sports medicine market (8% annual growth), the $55 billion US pressure injury market (4% annual growth), and the $14 billion US diabetic foot syndrome market (6.7% annual growth). We hold a robust intellectual property portfolio, including patents, trademarks, and know-how, complemented by exclusive proprietary components, protocols, and technology. Our devices are manufactured in the US and regulated by the FDA. We are currently seeking financing to initiate commercial manufacturing through a contract manufacturer, support product launch, and facilitate ongoing R&D and SG&A activities. With our projected sales, RLT anticipates achieving positive cash flow within 12 months of full funding."
Products & Services
Regain Warrior Medical Device
Our initial product is the Regain Warrior, an in-office portable therapeutic laser, representing the first of our patented medical devices. Prototypes of the Warrior are currently being used by clinicians and elite athletes. Incorporating the Warrior into rehabilitation results in faster and better recoveries. The Warrior offers fast, pain-free, non-contact treatments with zero downtime. It is positioned to excel in the $12 billion US sports medicine market (8% annual growth) (Cannacord), and the $14 billion US diabetic foot syndrome market (6.7% annual growth) (McKinsey). In the orthopedic space, taking a conservative view, assuming we achieve 1% penetration of only the physical therapy space, the value of that market to Regain is ~ $78 Million annually. If we achieve 1% penetration of the physician, surgeon and physical therapist orthopedic space, then that market is worth $1.35 Billion annually.
Media Gallery
video placeholder image
Regain Laser Therapy Image 1
Company Stats
Key metrics about Regain Laser Therapy
Fuel Level
Engagement metrics for Regain Laser Therapy
Fuel represents engagement and interest in this company from the Crowdigy community.
Are you the owner of Regain Laser Therapy?
Claim your company profile to respond to reviews, update your information, and connect with investors.
Claim This Company